Fosamax, Alendronate News

Feb. 8, 2012 -- Some drugs used to strengthen bones may increase the risk of an unusual type of fracture if patients take them for many years, a new study shows.

A research team led by UC Davis Health System scientists has developed a novel technique to enhance bone growth by using a molecule which, when injected into the bloodstream, directs the body's stem cells to travel to the surface of bones.

Experts said the move could greatly reduce the incidence of spine and hip fractures in nearly 30,000 older West Australians with mild forms of the disease.

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, has read with interest a report suggesting that patients with normal bone density can postpone retests.

Joe and Terry Graedon are authors of The People's Pharmacy book and host an award-winning health talk show on public radio.

Dear Dr. Donohue: I am a 69-year-old woman and take simvastatin and alendronate.

Women are in such danger of osteoporosis they need regular bone scans. That was conventional medical "wisdom" since the first lucrative bone drug surfaced over a decade ago.

Bernstein Liebhard LLP reports on a January 18, 2012 study questioning whether frequent bone density scans are necessary due to the slow rate at which osteoporosis progresses and the harmful side effects of bisphosphonates, such as Fosamax, used to treat the disease.